Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), the owner of RISE Dispensaries, announced on Tuesday that it has been given the green light for the repurchase pursuant to a normal course issuer bid of up to 10,486,951 of its subordinate voting shares from time to time over 12 months.

The Chicago and Vancouver-based company can spend up to $50 million for the repurchase program, as per a decision by the company's board of directors, of which Wendi A. Berger, one of many speakers at the Benzinga upcoming event, is a member.

Why It Matters

Ben Kovler, the company's chairman and CEO, said the move would result in "creating shareholder value without compromising our growth initiatives."

"This action was in the works before last week's announcement from the U.S. Department of Health and Human Services, which called …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.